Trauma and Remembering: From Neuronal Circuits to Molecules
Life October 26, 2022 DOI: 10.3390/life12111707 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Narrative review Peer reviewed |
|---|---|
| Keywords | Engram Traumatic memories Arousal |
| Citations | 8 |
| Key findings | Psychedelics may destabilize trauma-related engrams during retrieval, enabling their modification through psychotherapy. |
Abstract
Individuals with posttraumatic stress disorder (PTSD) experience intrusions of vivid traumatic memories, heightened arousal, and display avoidance behavior. Disorders in identity, emotion regulation, and interpersonal relationships are also common. The cornerstone of PTSD is altered learning, memory, and remembering, regulated by a complex neuronal and molecular network. We propose that the essential feature of successful treatment is the modification of engrams in their unstable state during retrieval. During psychedelic psychotherapy, engrams may show a pronounced instability, which enhances modification. In this narrative review, we outline the clinical characteristics of PTSD, its multifaceted neuroanatomy, and the molecular pathways that regulate memory destabilization and reconsolidation. We propose that psychedelics, acting by serotonin-glutamate interactions, destabilize trauma-related engrams and open the door to change them during psychotherapy.
Citations in the library
Cited by 4
- Traumatic Psychedelic Experiences. Current Topics in Behavioral Neurosciences April 29, 2025
- Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review World Journal of Psychiatry May 19, 2023
- Recalled childhood trauma and post-psychedelic trajectories of change in a mixed-methods study Scientific Reports November 27, 2025
- The experience of recalled trauma during psychedelic experiences and perceived links to subsequent extended difficulties: A mixed-methods study Research Square August 21, 2025
Cites 26
- MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine June 1, 2021
- The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects. ACS Pharmacology & Translational Science December 10, 2020
- The Hallucinogen N,N -Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator Science February 13, 2009
- Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. Journal of Psychopharmacology February 2, 2022
- Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine Journal of Neuroscience November 30, 2020
and 21 more in the library